1. Market Research
  2. > Pharmaceutical Market Trends
Benchmarking Pharma’s MSL Capabilities

Benchmarking Pharma’s MSL Capabilities

  • April 2018
  • ID: 5385567
  • Format: PDF

Summary

Table of Contents

Are you convinced your MSL teams are keeping up with evolving market practice?

The best medical science liaison (MSL) teams have made significant changes to adapt to a whole new world. The pharma companies getting the best results from their MSLs have been busy: widening their remit, embracing technology, and fine-tuning structure and focus. What does a forward-thinking MSL team now look like?

In March 2018, we interviewed 8 MSL leads from pharma companies in the US and Europe and found out how their MSL teams are staying current.
• How are MSL activities and priorities shifting in response to regulatory changes and funding restrictions?
• What can be done to keep and develop talented MSLs as the role becomes increasingly complex?
• Is there an optimum MSL team set-up? How many people; how many brands; when in the lifecycle is MSL introduced?
• How should digital tools be used for to deliver practical results rather than expensive promises?
• How can MSLs more cleverly collaborate and communicate internally whilst still maintaining the all-important commercial/MA firewall?
• What are the most current ways to measure MSL performance and demonstrate value?

What to expect from this report

This is your chance to compare. Find out if your MSLs are doing enough of the right activities in Benchmarking Pharma’s MSL Capabilities.

Scientific discussions with doctors are key – but a more sophisticated, structured and strategic role is now needed. We’ve found out how the new breed of multi-faceted MSLs are performing. This is the most current thinking available - entirely new qualitative research based on interviews conducted in March 2018. You definitely won’t read these current insights anywhere else.
• We identified the 14 MSL issues which are front of mind right now
• We explored these via an average of 30 targeted questions put to each expert
• Their responses provided 55 unique new insights
• Insights are supported by 95 directly quoted comments

Example insight included in Benchmarking Pharma’s MSL Capabilities

The need for on-demand MSLs is rising; HCPs want instant access to information and remote engagement will be a game changer in the future as medical affairs teams respond to this change. With a majority of physicians searching for information online about a particular product while the patient is with them, medical information must be quickly accessible. Pharma companies have an opportunity to harness technology that will direct people to the credible scientific information on their website, rather than just leaving it to a generic search engine and risk HCPs not finding accurate information. Companies must be agile to keep up with these demands, using digital technology, for example to provide on-demand MSLs, click-to-chat or intelligent rerouting, to provide the right amount of information to the customer as and when they demand it.

Example quote included in Benchmarking Pharma’s MSL Capabilities

"In the past couple of years, we ran a couple of pilot projects with virtual reality, where we utilised 3D Google Glass with short videos on the mechanism of action for a specific drug, trying to identify whether our customers, or at least some of them, would learn faster and appreciate that short inversion into virtual reality… Some of the customers were not interested and others were… There’s no one size that will fit all of our customers. But, having those tools is very important and it’s about the MSL’s ability to be flexible, and to tailor their interaction to particular customers.

The expert panel for Benchmarking Pharma’s MSL Capabilities
• Mark Rees-Saunders, Medical Affairs Excellence Lead, AstraZeneca UK
• Senior MSL Manager, Top 10 Pharma Company, UK
• MSL Director, Specialty Pharma Company, UK
• Carmen Sanchez Puyol, MSL Manager Spain and Portugal, Clovis Oncology
• Medical Science Liaison Manager, Top 10 Pharma Company, US
• Director, Oncology Medical Science Liaisons, Specialty Pharma Company, US
• Executive Director and Head of Medical Science Liaisons, Specialty Pharma Company, US
• Associate Director MSL & Medical Digital Transformation, Top 20 Pharma Company, US

Why FirstWord reports are different
• 100% new content: You won’t find old research presented as new. Guaranteed.
• Opinions you need to hear: We only interview experts with current, relevant experience.
• Professional researchers: The knowledge, experience and contacts to get the answers you need.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Augmented Reality and Virtual Reality Market in Healthcare: Focus on Component Type (Hardware, Software and Services) and Application Areas (Surgical Training, Rehabilitation, and Pain Management): Analysis and Forecast, 2019-2025

Global Augmented Reality and Virtual Reality Market in Healthcare: Focus on Component Type (Hardware, Software and Services) and Application Areas (Surgical Training, Rehabilitation, and Pain Management): Analysis and Forecast, 2019-2025

  • $ 5000
  • March 2019

Global Augmented Reality (AR) and Virtual Reality (VR) Market in Healthcare to Reach $11.14 Billion by 2025The global augmented reality (AR) and virtual reality (VR) in the healthcare market is a multi-billion ...

Virtual Reality Market by Offering, Technology, Device Type, Application and Geography - Global Forecast to 2024

Virtual Reality Market by Offering, Technology, Device Type, Application and Geography - Global Forecast to 2024

  • $ 5650
  • January 2019

Virtual reality market projected to grow at 33.47% CAGR during 2018–2024The virtual reality (VR) market is expected to grow from USD 7.9 billion in 2018 to USD 44.7 billion by 2024, at a CAGR of 33.47% ...

Display Market by Product, Panel Size, Industry And Geography - Global Forecast to 2024

Display Market by Product, Panel Size, Industry And Geography - Global Forecast to 2024

  • $ 5650
  • January 2019

Display panel market expected to grow at CAGR of 4.0% from 2019 to 2024The display panel market is expected to grow from USD 137.7 billion in 2019 to USD 167.7 billion by 2024, at a CAGR of 4.0% from 2019 ...


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on